Results 301 to 310 of about 10,520,123 (362)

Interleukin‐6 as a Key Biomarker in Facioscapulohumeral Dystrophy: Evidence From Longitudinal Analyses

open access: yesAnnals of Clinical and Translational Neurology, EarlyView.
ABSTRACT Objective Facioscapulohumeral muscular dystrophy type 1 (FSHD1) is a progressive neuromuscular disorder with no approved treatments. Identifying reliable biomarkers is critical to monitor disease severity, activity, and progression. Interleukin‐6 (IL‐6) has been proposed as a candidate biomarker, but longitudinal validation is limited ...
Jonathan Pini   +13 more
wiley   +1 more source

Artificial intelligence in digital pathology diagnosis and analysis: technologies, challenges, and future prospects. [PDF]

open access: yesMil Med Res
Zhang XM   +29 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy